BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12720172)

  • 1. DPC-4 (Smad-4) and K-ras gene mutations in biliary tract epithelium in children with anomalous pancreaticobiliary ductal union.
    Shimotake T; Aoi S; Tomiyama H; Iwai N
    J Pediatr Surg; 2003 May; 38(5):694-7. PubMed ID: 12720172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
    Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
    Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.
    Matsubara T; Sakurai Y; Zhi LZ; Miura H; Ochiai M; Funabiki T
    J Hepatobiliary Pancreat Surg; 2002; 9(3):312-21. PubMed ID: 12353142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
    Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
    Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
    Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
    World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
    Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
    J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
    Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
    Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factor for extrahepatic bile duct cancer in patients with anomalous pancreaticobiliary ductal union.
    Jung YS; Lee KJ; Kim H; Kim WH; Kim IG; Yoo BM; Kim JH; Kim MW
    Hepatogastroenterology; 2004; 51(58):946-9. PubMed ID: 15239220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor progression through epigenetic gene silencing of O(6)-methylguanine-DNA methyltransferase in human biliary tract cancers.
    Koga Y; Kitajima Y; Miyoshi A; Sato K; Kitahara K; Soejima H; Miyazaki K
    Ann Surg Oncol; 2005 May; 12(5):354-63. PubMed ID: 15915369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J; Niu J; Li M; Chiao PJ; Tsao MS
    Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
    Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
    Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
    Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
    J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
    Hanada K; Tsuchida A; Iwao T; Eguchi N; Sasaki T; Morinaka K; Matsubara K; Kawasaki Y; Yamamoto S; Kajiyama G
    Am J Gastroenterol; 1999 Jun; 94(6):1638-42. PubMed ID: 10364037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts.
    Iwase T; Nakazawa S; Yamao K; Yoshino J; Inui K; Yamachika H; Kanemaki N; Fujimoto M; Okushima K; Miyoshi H; Taki N; Nakamura Y; Mizutani S; Horibe Y; Masui T; Tatematsu M
    Hepatogastroenterology; 1997; 44(17):1457-62. PubMed ID: 9356872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial hyperplasia of the gallbladder in children with anomalous pancreaticobiliary ductal union.
    Tanno S; Obara T; Fujii T; Mizukami Y; Yanagawa N; Izawa T; Ura H; Kohgo Y
    Hepatogastroenterology; 1999; 46(30):3068-73. PubMed ID: 10626162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma.
    Moskaluk CA; Hruban RH; Kern SE
    Cancer Res; 1997 Jun; 57(11):2140-3. PubMed ID: 9187111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of c-Ki-ras oncogene and p53 immunocytochemistry in the gallbladder mucosa of an experimental dog model of anomalous arrangement of the pancreaticobiliary ducts.
    Sasaki K; Kunitomo K; Yagi K; Masamune K; Komi N; Tashiro S
    Tokushima J Exp Med; 1996 Dec; 43(3-4):101-6. PubMed ID: 9100457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
    Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.